Cannabis and gold - raw materials in their natural form
Gold, and currently cannabis in particular, are two commodities that are driving investors and the stock market. The alchemists, starting with the first attempts in ancient Egypt and in Hellenistic Greece, tried in vain to produce gold and silver. Gold still has to be laboriously extracted from the ground in the classic mining manner.
The one who is looking for gold in a particularly panoramic area and also has an extremely large property there and, of course, the necessary means to carry out research there, is in good hands. This is true of White Gold with its huge land package (439,000 hectares) in the White Gold District in the Yukon. The Company also has the $13 million estimated for the 2019 exploration program. High grade discoveries are to be expanded thereby. The programme is due to start shortly in 2019 with the support of high-ranking partners Agnico Eagle Mines and Kinross Gold.
In the case of cannabis, quality should only come from products made from the hemp plant. Even if various researchers are working on the artificial production. Whether cannabis is used for medical purposes or for private use, quality and safety are likely to be paramount. Deaths and illnesses caused by synthetic cannabis have already occurred. Cannabis is a natural drug and a component of the hemp plant.
In the current stock market hype about cannabis, an investor should inform himself carefully in order to identify really high-quality companies in the pool of cannabis companies. RavenQuest BioMed is a convincing company. With plants in Alberta and Ontario, research partnerships and business connections with Dutch Passion, for example, RavenQuest BioMed should be able to establish itself in the growth market of cannabis in order to be lucrative.
Current corporate information and press releases from White Gold (https://www.resource-capital.ch/en/companies/whitegoldcorp.html) and RavenQuest BioMed (https://www.resource-capital.ch/en/companies/ravenquest-biomed-inc.html).
In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the English version of these messages applies.
Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: https://www.resource-capital.ch/en/disclaimer.html